While one of the most lethal of all cancers (average one-year survival rate is less than 30 percent), brain cancer affects comparatively fewer people than other cancers and attracts less research funding. There is a critical need to foster innovation and fresh thinking to pioneer progress and develop new treatments for patients with brain cancer.
Your investment will help attract the best and brightest researchers to the field of brain cancer. Young Investigator Awards encourage and invest in physician-scientists who are building their careers in translational medicine. The awards provide support for a three-year period in neuro-oncology and address key scientific and medical challenges in the development of effective brain cancer therapies.